Keratitis with Cetuximab;Heparin-Induced Thrombocytopenia with Fondaparinux;Anaphylactic Shock with Cefuroxime Axetil;Cross-Reactivity between Vancomycin and Teicoplanin;Olanzapine-Associated Eyelid Edema;Another ADR with Olanzapine – Late-Onset Neuroleptic Malignant Syndrome;A Series of Published Drug Reviews of Specific ADRs

Abstract

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the Food and Drug Administration's (FDA) medWatch program (800-FDA-1088). If you have reported an interesting preventable ADR to medWatch, please consider sharing the account with our readers.